What is Sciome?
Sciome LLC operates as a specialized research and technology consultancy, providing advanced informatics solutions tailored for the life sciences sector. The company distinguishes itself through the application of quantitative methods and high-efficiency informatics to solve intricate scientific problems. Their service portfolio spans bioinformatics, cheminformatics, and text-mining, catering to a high-profile client base that includes US Federal Government agencies, global pharmaceutical entities, and academic research institutions.
By deploying novel data science frameworks, Sciome enables its partners to navigate data-rich environments, facilitating accelerated discovery and improved decision-making. The firm's multidisciplinary team of scientists serves as a critical asset, allowing the organization to maintain a competitive edge in a market that increasingly demands precision, scalability, and deep domain expertise.
How much funding has Sciome raised?
Sciome has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Sciome
PPP
Public-Private Partnership
What's next for Sciome?
With the successful closure of this late-stage funding, Sciome is poised to enter a phase of accelerated growth and market expansion. The strategic deployment of these funds will likely focus on the enhancement of their core informatics platforms and the broadening of their service offerings to meet the evolving needs of the biotechnology and pharmaceutical industries.
Looking ahead, the company is expected to prioritize the integration of emerging artificial intelligence and machine learning capabilities into its existing suite of analytical tools. This evolution will not only strengthen their current service delivery but also open new avenues for research partnerships. As the life sciences sector continues to grapple with the challenges of big data, Sciome's commitment to enabling science through analytical informatics positions it as a vital partner for organizations seeking to transform raw data into meaningful scientific breakthroughs.
